Miyako Kishimoto

1.5k total citations
70 papers, 849 citations indexed

About

Miyako Kishimoto is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Genetics. According to data from OpenAlex, Miyako Kishimoto has authored 70 papers receiving a total of 849 indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Endocrinology, Diabetes and Metabolism, 17 papers in Surgery and 12 papers in Genetics. Recurrent topics in Miyako Kishimoto's work include Diabetes Management and Research (20 papers), Diabetes Treatment and Management (15 papers) and Diabetes and associated disorders (10 papers). Miyako Kishimoto is often cited by papers focused on Diabetes Management and Research (20 papers), Diabetes Treatment and Management (15 papers) and Diabetes and associated disorders (10 papers). Miyako Kishimoto collaborates with scholars based in Japan, United States and Sri Lanka. Miyako Kishimoto's co-authors include Mitsuhiko Noda, Hiroshi Kajio, Ritsuko Yamamoto‐Honda, Hiroshi Noto, Tetsuro Tsujimoto, Atsushi Goto, Masafumi Kakei, Akio Kimura, Yoshihiko Takahashi and Masato Odawara and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Miyako Kishimoto

66 papers receiving 802 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Miyako Kishimoto Japan 18 488 183 138 135 100 70 849
Ridha Arem United States 18 717 1.5× 156 0.9× 114 0.8× 146 1.1× 55 0.6× 37 998
Mihail Zilbermint United States 16 513 1.1× 271 1.5× 64 0.5× 129 1.0× 83 0.8× 55 783
Mathew John India 16 627 1.3× 186 1.0× 127 0.9× 127 0.9× 69 0.7× 57 1.1k
Fahim Ebrahimi Switzerland 18 348 0.7× 136 0.7× 89 0.6× 181 1.3× 83 0.8× 72 1.0k
Evgenia Gourgari United States 14 551 1.1× 317 1.7× 229 1.7× 148 1.1× 108 1.1× 37 858
Doina Catrinoiu Romania 14 343 0.7× 114 0.6× 53 0.4× 178 1.3× 100 1.0× 27 645
Georgia Soldatos Australia 17 392 0.8× 152 0.8× 125 0.9× 85 0.6× 63 0.6× 45 908
Peter S. Hamblin Australia 16 451 0.9× 109 0.6× 139 1.0× 135 1.0× 35 0.3× 54 755
Mark Aagren United States 17 716 1.5× 133 0.7× 149 1.1× 110 0.8× 37 0.4× 42 1.1k

Countries citing papers authored by Miyako Kishimoto

Since Specialization
Citations

This map shows the geographic impact of Miyako Kishimoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miyako Kishimoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miyako Kishimoto more than expected).

Fields of papers citing papers by Miyako Kishimoto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Miyako Kishimoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miyako Kishimoto. The network helps show where Miyako Kishimoto may publish in the future.

Co-authorship network of co-authors of Miyako Kishimoto

This figure shows the co-authorship network connecting the top 25 collaborators of Miyako Kishimoto. A scholar is included among the top collaborators of Miyako Kishimoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Miyako Kishimoto. Miyako Kishimoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Kishimoto, Miyako, Takuya Ishikawa, & Masato Odawara. (2020). Behavioral changes in patients with diabetes during the COVID-19 pandemic. Diabetology International. 12(2). 241–245. 42 indexed citations
3.
Kishimoto, Miyako, et al.. (2017). Successful glycemic control using a flash glucose monitoring system for a pregnant woman with diabetes: a case report. Journal of Diabetes & Metabolic Disorders. 16(1). 44–44. 2 indexed citations
4.
Tsujimoto, Tetsuro, Ritsuko Yamamoto‐Honda, Hiroshi Kajio, et al.. (2016). Accelerated decline of renal function in type 2 diabetes following severe hypoglycemia. Journal of Diabetes and its Complications. 30(4). 681–685. 4 indexed citations
5.
Tsujimoto, Tetsuro, Takehiro Sugiyama, Ritsuko Yamamoto‐Honda, et al.. (2016). Beneficial effects through aggressive coronary screening for type 2 diabetes patients with advanced vascular complications. Medicine. 95(33). e4307–e4307. 3 indexed citations
6.
Akiyama, Koichi, Fumihiko Takeuchi, Masato Isono, et al.. (2014). Systematic Fine-Mapping of Association with BMI and Type 2 Diabetes at the FTO Locus by Integrating Results from Multiple Ethnic Groups. PLoS ONE. 9(6). e101329–e101329. 8 indexed citations
7.
Kishimoto, Miyako & Mitsuhiko Noda. (2014). Effects of Exenatide in a Morbidly Obese Patient with Type 2 Diabetes. Diabetes Therapy. 5(1). 323–332. 3 indexed citations
8.
Kishimoto, Miyako & Mitsuhiko Noda. (2014). The factors that limit activities of certified diabetes educators in Japan: a questionnaire survey. SpringerPlus. 3(1). 611–611. 4 indexed citations
9.
Tsujimoto, Tetsuro, Ritsuko Yamamoto‐Honda, Hiroshi Kajio, et al.. (2014). Prediction of 90-day mortality in patients without diabetes by severe hypoglycemia: blood glucose level as a novel marker of severity of underlying disease. Acta Diabetologica. 52(2). 307–314. 39 indexed citations
10.
Kishimoto, Miyako & Mitsuhiko Noda. (2014). Additive Effects of Miglitol and Anagliptin on Insulin-Treated Type 2 Diabetes Mellitus: A Case Study. Clinical Drug Investigation. 35(2). 141–147. 2 indexed citations
11.
Imai, Kenjiro, Tetsuro Tsujimoto, Atsushi Goto, et al.. (2014). Prediction of response to GLP-1 receptor agonist therapy in Japanese patients with type 2 diabetes. Diabetology & Metabolic Syndrome. 6(1). 110–110. 19 indexed citations
12.
Imai, Kenjiro, Miyako Kishimoto, Tetsuro Tsujimoto, et al.. (2013). Successful Treatment of Chronic Intractable Itching Using Oral Pregabalin in a Patient with Diabetes and Systemic Prurigo Nodularis: A Case Report of an Iliopsoas Muscle Abscess. Internal Medicine. 52(23). 2629–2633. 7 indexed citations
13.
Kishimoto, Miyako. (2013). Teneligliptin: a DPP-4 inhibitor for the treatment of type 2 diabetes. Diabetes Metabolic Syndrome and Obesity. 6. 187–187. 99 indexed citations
14.
Kishimoto, Miyako & Mitsuhiko Noda. (2012). Diabetes care: After the Great East Japan Earthquake. Journal of Diabetes Investigation. 4(1). 97–102. 17 indexed citations
15.
Kishimoto, Miyako & Mitsuhiko Noda. (2012). Effect of the Addition of Sitagliptin and Miglitol on Insulin-Treated Type 2 Diabetes. Diabetes Therapy. 3(1). 11–11. 7 indexed citations
16.
Tsujimoto, Tetsuro, Hiroshi Kajio, Yoshihiko Takahashi, et al.. (2011). Asymptomatic coronary heart disease in patients with type 2 diabetes with vascular complications: a cross-sectional study. BMJ Open. 1(2). e000139–e000139. 15 indexed citations
17.
Kishimoto, Miyako, Yasuhiko Okimura, Genzo Iguchi, et al.. (2003). The R271W mutant form of Pit-1 does not act as a dominant inhibitor of Pit-1 action to activate the promoters of GH and prolactin genes. European Journal of Endocrinology. 148(6). 619–625. 11 indexed citations
18.
Kishimoto, Miyako, et al.. (1991). Lipoma of the esophagus report of a case. 45(9). 873–877. 1 indexed citations
19.
UEDA, Hiroo, et al.. (1990). Mucosal Bridge Formation in Malignant Lymphoma of the Stomach: -Report of A Case-. Acta gastro-enterologica belgica. 32(7).
20.
Kishimoto, Miyako, et al.. (1965). [Effect of vitamin B12 on reduced visual function due to glaucoma].. PubMed. 16(3). 291–7. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ridha Arem Breakdown of academic impact, for papers by Mihail Zilbermint Breakdown of academic impact, for papers by Mathew John Breakdown of academic impact, for papers by Fahim Ebrahimi Breakdown of academic impact, for papers by Evgenia Gourgari Breakdown of academic impact, for papers by Doina Catrinoiu Breakdown of academic impact, for papers by Georgia Soldatos Breakdown of academic impact, for papers by Peter S. Hamblin Breakdown of academic impact, for papers by Mark Aagren
Rankless by CCL
2026